Report overview
The global Hypertension Medications market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Calcium Channel Blockers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hypertension Medications include Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals and Huahai Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
High blood pressure is a common condition that affects the body's arteries. It's also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.
This report aims to provide a comprehensive presentation of the global market for Hypertension Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypertension Medications. This report contains market size and forecasts of Hypertension Medications in global, including the following market information:
Global Hypertension Medications Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Hypertension Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypertension Medications Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Hypertension Medications Market Segment Percentages, by Type, 2023 (%)
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Blockers
Beta Blockers
Compound Drugs
Diuretics
Others
Global Hypertension Medications Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Hypertension Medications Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Hypertension Medications Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Hypertension Medications Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypertension Medications revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Hypertension Medications revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
AstraZeneca
Bayer
Sanofi
Boehringer Ingelheim
Merck
Lupin Pharmaceuticals
Huahai Pharmaceutical
Jiangsu Jibeier Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Chengdu Easton Biopharmaceuticals
Qingdao Huanghai Pharmaceutical
CR Double-Crane
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypertension Medications, market overview.
Chapter 2: Global Hypertension Medications market size in revenue.
Chapter 3: Detailed analysis of Hypertension Medications company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypertension Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
